Teva gets European OK to sell generic of Lilly’s Evista
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
Health Care & Life Sciences
Articles
Lilly asks shareholders to lower takeover barrier
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
WellPoint’s health insurance rate hike spurs legislative inquiry
The furor over WellPoint Inc.’s premium hikes have migrated from California to Indiana, where state lawmakers held a
high-profile hearing.
Indiana companies that serve pharmaceutical industry grew in 2009
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
Vortek Surgical moving HQ to Brownsburg, adding 60 jobs
Indianapolis-based Vortek Surgical LLC will relocate to Brownsburg, expanding its headquarters, manufacturing and distribution
operations and creating more than 60 jobs in the next three years.
Hamilton County ranked Indiana’s healthiest county
Nationwide report ranks Marion County 87th out of 92 Indiana counties in health factors and 80th in health outcomes.
WellPoint rate hikes spark protest in Indianapolis
Congressman Andre Carson will make remarks Thursday during a public chastising of Indianapolis-based health insurer for 21-percent rate
hike on individuals.
WellPoint, insurance commissioner get earful from lawmakers
State House insurance committee chair grills executives about WellPoint’s 21-percent premium increase for individual policyholders
in Indiana.
Lilly settles Arkansas Zyprexa suit for $18.5M
Arkansas Attorney General Dustin McDaniel on Tuesday announced an $18.5 million settlement of a lawsuit with Eli Lilly &
Co. over off-label marketing of the anti-psychotic drug Zyprexa.
State lawmakers to probe WellPoint premium hikes
Three WellPoint executives will be on hand Wednesday morning to answer questions about premium increases on its individual
policies, which have risen as high as 39 percent this year.
Pfizer’s Viagra patent partially rejected in Lilly fight
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn’t different
enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against
Eli Lilly and Co. over its rival Cialis drug.
Purdue to get $12M to help small health providers
Stimulus funds will help university’s technical assistance service show doctors and nurses in small groups and in medically under-served areas how to adopt medical-records technologies.
WellPoint delays investor meeting to testify on rate flap
The Indianapolis-based insurer, preparing for Congressional testimony on proposed premium increases in California, says its
earnings forecast is now less clear.
WellPoint hits bottom with customers
Even before WellPoint dissatisfied President Obama over its rate increases in California, it wasn’t doing so hot satisfying
its actual customers, according to the American Customer Satisfaction Index.
Q&A: Dr. John Fitzgerald
The Indiana Clinic, launched about a year ago, has signed 412 physicians as employees, and is still working
toward a goal of as many as 1,500 by 2011. The clinic, a joint venture of Clarian Health and the Indiana University
School of Medicine, is headed by Dr. John Fitzgerald. He discussed the progress.
Indiana part of national medical school surge
Marian University’s planned medical school is one of two dozen nationally, but budget cuts are forcing Indiana University to retreat
on enrollment expansion.
Could WellPoint woes breathe life into health reform?
The firestorm created this week by Indianapolis-based health insurer WellPoint’s spike in premiums could resurrect some parts
of
the languishing health reform bills.
Clarian, IU plan $100 million neurosciences center
Clarian Health and the Indiana University School of Medicine want their planned neurosciences hub to become a destination
for patients suffering
from brain, nerve and mental maladies—and for the government and industry research dollars that can
fuel advances in care.
Wishard parent ‘ecstatic’ about cheap debt – so far
The Health & Hospital Corporation of Marion County got good news in its first round of borrowing to finance a new Wishard
Hospital: so far, it is paying less than planned.
Startup VoCare Inc. might move to find venture capital dollars
A Lebanon-based startup wants to build a call center here and add up to 300 jobs, but state and local officials are struggling
with a big obstacle to keeping the company here.